Skip to search formSkip to main contentSkip to account menu

Cytostasan

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

bendamustine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Bendamustine: something old, something new
BackgroundBendamustine (Treanda, Ribomustin) is a water-soluble, bifunctional chemotherapeutic agent that also has potential… 
Review
2009
Review
2009
Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
1991
1991
[Pharmacokinetics of bendamustin (Cytostasan) in B6D2F1-mice].
The pharmacokinetics of bendamustine, (1; Cytostasan), an alkylating antineoplastic agent of the N-lost group, was investigated… 
1991
1991
Therapieergebnisse und toxische Nebenwirkungen der Kombination Cytostasan, Adriamycin und Vincristin als „Second line“-Therapie beim metastasierten Mammakarzinom
Remission rates of 30-50% can be obtained using different cytostatic combinations in second line therapy of metastatic breast… 
1991
1991
Hepatobiliary elimination of bendamustin (Cytostasan) in rats.
Biliary excretion of bendamustin (Cytostasan, 5-[bis(2-chloroethyl)amino]-i-methylbenzimidazole-2-butyric acid; 1) and its… 
1991
1991
[Therapeutic results and toxic side effects of the cytostasan, adriamycin and vincristine combination as second line therapy in metastatic breast cancer].
Remission rates of 30-50% can be obtained using different cytostatic combinations in second line therapy of metastatic breast… 
1989
1989
[Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer].
Remission rate of 30-50% can be obtained by different cytostatic combinations in second-line-therapy of the metastasized breast… 
1987
1987
Hydrolyseprodukte des Cancerostaticums Cytostasan (Bendamustin).
1986
1986
Antineoplastic activity and toxicity of some alkylating cytostatics (cyclophosphamide, CCNU, cytostasan) encapsulated in liposomes in different murine tumour models.
The encapsulation of Cyclophosphamide in MLV (PC:CH 1:1) revealed a total loss of antineoplastic activity in the P 388 tumour… 
1980
1980
Effect of a membrane-stabilizing compound on calcium binding to the plasma membrane of Acanthamoeba castellanii.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)